Genetic mechanisms of schizophrenia
Abstract
In the article, the authors review modern approaches to explaining the genetic determination of schizophrenia, which has a complex multi-level nonlinear character. The evolution of views on the relationship of genes and disease in the context of the influence of hypothetical environmental factors is reflected. Various methodological approaches to studying the role of genetic factors of schizophrenia in a comparative vein are discussed, and problematic issues of such studies are raised from a conceptual perspective.
An analytical review is based on the mention of literature data, which are the primary source of various ideological approaches to the interpretation of the role of genes in the occurrence of schizophrenia.
About the Authors
M. G. Devyaltovskaya
ГУ «Республиканский научно-практический центр «Мать и дитя»
Belarus
Belarus
I. M. Goloenko
ГНУ «Институт генетики и цитологии НАН Беларуси»
Belarus
Belarus
O. A. Skugarevsky
УО «Белорусский государственный медицинский университет»
Belarus
Belarus
References
1. Van der Merwe C., Passchier R., Mufford M. et al. Polygenic risk for schizophrenia and associated brain structural changes: A systematic review // Compr Psychiatry. – 2019. – Vol. 88. – P. 77–82.
2. Schork J., Tiffany A., Greenwood and David L. Braff Statistical Genetics Concepts and Approaches in Schizophrenia and Related Neuropsychiatric // Research Nicholas Schizophrenia Bulletin. – 2007. – Vol. 33(1). – P. 95–104.
3. Gottesman II, Schizophrenia genesis: the origins of madness. – Henry Holt & Company Inc., New York, USA, 1991. – 296 pp.
4. Kirov G, Michael C, O’Donovan, and Michael J. Owen Finding schizophrenia genes. // The Journal of Clinical Investigation. – 2005. – Vol. 115(6). – P. 1440–48.
5. Skogstrand K., Hagen C. M., Borbye-Lorenzen N. Reduced neonatal brain-derived neurotrophic factor is associated with autism spectrum disorders // Transl Psychiatry. – 2019. – Vol. 9(1). – P. 252.
6. Iannitelli A., Quartini A., Tirassa P. Schizophrenia and neurogenesis: A stem cell approach // Neurosci. Biobehav. Rev. – 2017. – Vol. 80. – P.414–442.
7. Seidman LJ, Mirsky AF. Evolving Notions of Schizophrenia as a Developmental Neurocognitive Disorder // J. Int Neuropsychol Soc. – 2017. – Vol. 23(9–10). – P. 881–892.
8. Obi-Nagata K., Temma Y., Hayashi-Takagi A. Synaptic functions and their disruption in schizophrenia: From clinical evidence to synaptic optogenetics in an animal model // Proc Jpn. Acad. Ser. B. Phys. Biol. Sci. – 2019. – Vol. 95 (5). – P. 179–197.
9. Голимбет ВЕ. Генетика шизофрении // Журн неврол и психиат. – 2003. – Vol. 103. № 3. – P. 58–67.
10. Fallin MD, Pulver E, et all. Bipolar I Disorder and Schizophrenia: A 440-Single-Nucleotide Polymorphism Screen of 64 Candidate Genes among Ashkenazi Jewish Case-Parent Trios // Am.J. Hum.Genet. – 2005. – Vol. 77. – P. 918–36.
11. O’Donovan MC, Williams NM, and Owen MJ. Recent advances in the genetics of schizophrenia. // Human Molecular Genetics. – 2003. – Vol. 12(2). – P. 125–133.
12. Millar JK, Christie S, Anderson S et al. Genomic structure and localisation within a linkage hotspot of Disrupted In Schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia // Mol Psychiatry. – 2001. – Vol. 6. № 2. – P. 173–8.
13. Nicodemus KK, Kolachana BS, Vakkalanka R, Straub RE, Giegling I, Egan MF, Rujescu D, Weinberger DR. Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia.Clinical Brain Disorders Branch,Hum Genet. – 2007. – Vol. 120. № 6. – P. 889–906.
14. Chen QY, Chen Q, Feng GY, Lindpaintner K, Wang LJ, Chen ZX, Gao ZS, Tang JS, Huang G, He L. Case-control association study of Disrupted-in-Schizophrenia-1 (DISC1) gene and schizophrenia in the Chinese population // J Psychiatr Res. – 2007. – Vol. 41. № 5. – P. 428–34.
15. Rosalinda C. Roberts Disrupted in Schizophrenia (DISC1): Integrating Clinical and Basic Findings. // Schizophrenia Bulletin . – 2007. – Vol. 33. № 1. – P. 11–15.
16. http://www.schizophreniaforum.org/res/sczgene/geneoverview.asp?geneid=238
17. Hodgkinson CA, Goldman D, Jaeger J et al. Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder.// Am J Hum Genet. – 2004. – Vol. 75. № 5. – P. 862–72.
18. Rapoport JL, Addington AM, Frangou S, et al. The neurodevelopmental model of schizophrenia: update 2005 // Mol Psychiatry. – 2005. – Vol. 10. – P. 434–49.
19. Robertson S, Hori S, Powell K. Schizophrenia:an integrative approach to modelling a complex disorder // J Psychiatry Neurosci. – 2006. – Vol. 31. № 3. – P. 157–67.
20. Mittal VA, Ellman LM, Cannon TD. Gene-environment interaction and covariation in schizophrenia: the role of obstetric complications.// Schizophr Bull. – 2008. – Vol. 34. № 6. – P. 1083–94.
21. Zammit S, Lewis S, Gunnell D, Smith GD. Schizophrenia and neural tube defects: comparisons from an epidemiological perspective.// Schizophr Bull. – 2007. – Vol. 33. № 4. – P. 853–8.
22. Bellivier F. Schizophrenia, antipsychotics and diabetes: genetic aspects // Eur Psychiatry. – 2005. – Vol. 20. – P. 335–9.
23. Brown AS, Susser ES. In utero infection and adult schizophrenia // Ment Retard Dev Disabil Res Rev. – 2002. – Vol. 8. – P. 51–57.
24. Bagalkote H, Pang D, Jones PB. Maternal influenza and schizophrenia // Int J Ment Health. – 2001. – Vol. 29. – P. 3–21.
25. Brown AS, Cohen P, Harkavy-Friedman J, Babulas V, Malaspina D, Gorman JM, Susser ES. Prenatal rubella, premorbid abnormalities, and adult schizophrenia // Biol Psychiatry. – 2001. –Vol. 49. – P. 473–486.
26. Brown AS. Prenatal infection and adult schizophrenia: a review and synthesis.// Int J Ment Health. – 2001. – Vol. 29. – P. 22–37.
27. Gilmore JH, Jarskog LF. Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia.// Schizophr Res. – 1997. – Vol. 24. – P. 365–367.
28. Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Wagner RL, Yolken RH. Maternal cytokine levels during pregnancy and adult psychosis // Brain Behav Immun. – 2001. – Vol. 15. – P. 411–420.
29. Brown A., Hooton J, Schaefer C, Zhang H, et al. Elevated Maternal Interleukin-8 Levels and Risk of Schizophrenia in Adult Offspring // Am J Psychiatry. – 2004. – Vol. 161. – P. 889–895.
30. Meyer U, Feldon J, Schedlowski M, Yee BK. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia // Neurosci Biobehav Rev. – 2005. – Vol. 29. – P. 913–947.
31. Meyer U, Yee BK, Feldon J. The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse? // Neuroscientist. – 2007. – Vol. 3. № 3. – P. 241–56.
32. Meyer U, Nyffeler M, Schwendener S, Knuesel I, Yee B and Feldon J. Relative Prenatal and Postnatal Maternal Contributions to Schizophrenia-Related Neuronhemical Dysfunction after In Utero Immune Challenge // Neuropsychopharmacology. – 2008. – Vol. 33. – P. 441–456.
33. Fatemi SH, Reutiman TJ, Folsom TD, Huang H, Oishi K, Mori S, Smee DF, Pearce DA, Winter C, Sohr R, Juckel G. Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders// Schizophr Res. – 2008. – Vol. 99. № 3. – P. 56–70.
34. Done DJ, Johnstone EC, Frith CD, Golding J, Shepherd PM, Crow TJ. Complications of pregnancy and delivery in relation to psychosis in adult life: data from the British perinatal mortality survey sample // BMJ. – 1991. – Vol. 302. – P. 1576–1580.
35. Schmidt-Kastner R, van Os J, W M Steinbusch H, Schmitz C. Gene regulation by hypoxia and the neurodevelopmental origin of schizophrenia // Schizophr Res. – 2006. – Vol. 84. № 2–3. – P. 253–71.
36. Nicodemus KK, Marenco S, Batten AJ, Vakkalanka R, Egan MF, Straub RE, Weinberger DR. Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk / Mol Psychiatry. 2008 Sep;13(9):873–7.
37. Lieshout R, Lakshmi P. Voruganti M. Diabetes mellitus during pregnancy and increased risk of schizophrenia in offspring: a review of the evidence and putative mechanisms // J Psychiatry Neurosci. – 2008. – Vol. 33. № 5. – P. 395–404.
38. Mukherjee S, Schnur DB, Reddy R. Family history of type 2 diabetes in schizophrenic patients // Lancet. – 1989. – Vol. 1. – P. 495.
39. Lewis SJ, Zammit S, Gunnell D, Smith GD. A meta-analysis of the MTHFR C677T polymorphism and schizophrenia risk // Am J Med Genet B Neuropsychiatr Genet. – 2005. – Vol. 5. – P. 2–4.
40. Hermans MP, Gala JL, Buysschaert M. The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetes // Diabet Med. – 2006. – Vol. 23. № 5. – P. 529–36.
41. Dalal A, Pradhan M, Tiwari D, Behari S, Singh U, Mallik GK, Das V, Agarwal S. MTHFR 677C-->T and 1298A-->C polymorphisms: evaluation of maternal genotypic risk and association with level of neural tube defect.// Gynecol Obstet Invest. – 2007. – Vol. 63. № 3. – P. 146–50.
42. Jongbloet P, Verbeek A, Roeleveld M. Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms resulting in suboptimal oocyte maturation: a discussion of folate status, neural tube defects, schizophrenia, and vasculopathy // Journal of Experimental and Clinical Assisted Reproduction. – 2008. – P. 5:5.
43. Homberger A, Linnebank M, Winter C, Willenbring H, Marquardt T, Harms E, Koch HG. Genomic structure and transcript variants of the human methylenetetrahydrofolate reductase gene // Eur J Hum Genet. – 2000. – Vol. 8. № 9. – P. 725–9.
44. Rodríguez-Guillén Mdel R, Torres-Sánchez L, Chen J, Galván-Portillo M, Blanco-Muñoz J, Anaya MA, Silva-Zolezzi I, Hernández-Valero MA, López-Carrillo L. Maternal MTHFR polymorphisms and risk of spontaneous abortion // Salud Publica Mex. – 2009. – Vol. 51. № 1. – P. 19–25.
45. Chen CP. Review. Prenatal diagnosis, fetal surgery, recurrence risk and differential diagnosis of neural tube defects // Taiwan J Obstet Gynecol. – 2008. – Vol. 47. № 3. – P. 283–90.
46. Tandon R, Keshavan MS, Nasrallah HA. Schizophrenia, «just the facts» what we know in 2008. 2. Epidemiology and etiology / Schizophr Res. – 2008. – Vol. 102. № 1–3. – P. 1–18.
47. Коненков ВИ. Медицинская и экологическая иммуногенетика. – СО РАМН, Новосибирск. 1999. – 250 с.
48. Ковалевская ТС, Вассерман НН, Твесская СМ, Поляков АВ. Генетические аспекты невынашивания беременности // Медицинская генетика. 2003. – Т. 2. № 11. – С. 422.
49. Yang Q, Khoury MJ, Botto L, Friedman JM, Flanders WD. Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes // Am J Hum Genet. – 2003. – Vol. 72. № 3. – P. 636–49.
50. Peter K, Christina GS, Palmer AJ, Woodward JA, et al. RHD maternal–fetal genotype incompatibility and schizophrenia: extending the MFG test to include multiple siblings and birth order // European Journal of Human Genetics. – 2004. – Vol. 12. – P. 192–198.
51. Беспалова ОН, Ажанова ОН, Иващенко ИН, Асеев МВ. и др. Генетические факторы предрасположенности к привычному невынашиванию беременности ранних сроков. // Журнал акушерства и женских болезней. – 2001. – Том. ХLX. № 2. – С. 8–13.
52. Pae CU, Yu HS, Kim JJ, Kim W, Lee CU, Lee SJ, Jun TY, Lee C, Paik IH, Serretti A. Glutathione S-transferase M1 polymorphism may contribute to schizophrenia in the Korean population // Psychiatr Genet. – 2004. – Vol. 14. № 3. – P. 147–50.
53. Harada S, Tachikawa H, Kawanishi Y. Glutathione S-transferase M1 gene deletion may be associated with susceptibility to certain forms of schizophrenia. // Biochem Biophys Res Commun. – 2001. – Vol. 281. № 2. – P. 267–71.
54. Saadat M, Mobayen F, Farrashbandi H. Links Genetic polymorphism of glutathione S-transferase T1: a candidate genetic modifier of individual susceptibility to schizophrenia // Psychiatry Res. – 2007. – Vol. 153. № 1. – P. 87–91.
55. Жариков Н. М. Эпидемиологические исследования в психиатрии / Н. М. Жариков – М.: Медицина, 1977. – 173 с.
56. Внуков В. А. О дефекте при шизофреническом процессе и об отдельных видах его / В. А. Внуков // Труды 2-го Всесоюз. съезда невропатол. и психиатр. – М., 1937. – Вып. 2. – С. 466–470.
57. Карманное руководство к МКБ-10: Классификация психических и поведенческих расстройств (с глоссарием и исследовательскими диагностическими критериями) / Сост. Дж. Э. Купер; Под ред. Дж. Э. Купера / пер. с англ. Д. Полтавца. – К.: Сфера, 2003. – 464 с.
58. Эдельштейн А. О. Исходные состояния шизофрении / А. О. Эдельштейн. – М., 1938. – 114 с.
59. Кабанов М. М. Реабилитация психически больных / М. М. Кабанов. – 2 изд. – Ленинград, 1985. – 216 с.
60. Лакин Г. Ф. Биометрия: Учеб. пособие для биол. спец. вузов / Г. Ф. Лакин. – 4 изд., перераб. и доп. – М.: Высш. шк., 1990. – 352 с.
61. Mathew C. C. The isolation of high molecular weight eucaryotic DNA // Meth. Mol. Biol., Human Press. – 1984. – V. 2. Walker J. M., (ed). – P. 31–34.
62. Гелда А. П. Оценка биологических патогенных факторов, способствующих формированию пограничной психической дезадаптации у младших школьников / А. П. Гелда, И. М. Желдак, Т. В. Докукина // Социально-психологическая реабилитация населения, пострадавшего от экологических и техногенных катастроф. YII Международн. конф., Минск, Республика Беларусь, 30 мая - 2июня 2000 г. Матер. конф. – Мн., 2000. – С. 83.
63. Цыбин А. К. Совершенствование оздоровительной работы в школах / А. К. Цыбин // Здравоохранение – 1999. – № 4. – С. 25–27.
64. Доклад о состоянии здравоохранения в мире. Психическое здоровье: новое пони-мание, новая надежда. – ВОЗ, 2001. – С. 215.
65. Уорнер Р. Шизофрения и среда: Инновации в лечебной практике, политике и в области массовой коммуникации / Р. Уорнер / пер. с англ. С. Альошкиной. – Киев: Сфера, 2004. – 198 с.
66. Boog G. Obstetrical complications and further schizophrenia of the infant: a new medi-colegal threat to the obstetrician? / G. Boog // J. Gynecol. Obstet. Biol. Reprod (Paris). Review. French. 2003. Dec. – 2003. – Vol. 32, № 8 Pt 1. – P. 83–92.
67. Dalen P. Deviant birth season distribution: does it offer a clue to the aetiology of schi-zophrenia? / P. Dalen – Berlin: Springer-Verlag, 1990. – Vol. 2. – Р. 7–13.
68. Kunugi H. Myrreay Obstetric complications and schizophrenia: prenatal underdevelopment and subsequent neurodevelopment impairment / H. Kunugi, S. Nanko // Brit. J. Psychiat. – 2001. – Vol. 40. – S. 25–29.
69. McNeil T. F. Relationship of obstetric complications and differences in size of brain structures in monozygotic twin pairs discordant for schizophrenia / T. F. McNeil, E. Cantor-Great, D. R. Weinberger // Amer. J. Psychiat. – 2000. – Vol. 157, № 2. – S. 203–212.
70. Левданский О. Д., Кушнеревич Е. И., Сивицкая Л. Н. Анализ полиморфизма генов GSTM1 и GSTT1 в популяции белорусов // Молодежь в науке – 2007: прил. к журн. «Весцi Нацiянальнай акадэмii навук Беларусi». В 4 ч. Ч. 1 Серия биологических наук; серия медицинских наук / редкол. Серии биол. Наук: И. Д. Волотовский (гл. ред.), А. Г. Лобанок [и др.]; редкол. Серии мед, наук: Е. Ф. Конопля (гл. ред.), А. Г. Мрочек [и др.]. – Минск: Белорус. Наука, 2008. – С. 153–156.
71. Winter C, Djodari-Irani A, Sohr R, Morgenstern R, Feldon J, Juckel G, Meyer U. Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia // Int J Neuropsychopharmacol. – 2008. – Vol. 28. – P. 1–12.
Review
For citations:
Devyaltovskaya M.G., Goloenko I.M., Skugarevsky O.A. Genetic mechanisms of schizophrenia. Military Medicine. 2020;(2):118-126. (In Russ.)
Views:
43
JATS XML
Email this article 